Reaction

Hepatojugular Reflux reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 166 reports · 5 co-occurring drugs

As of the last recalculation, Hepatojugular Reflux appears in 166 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE (PRR 185.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Esomeprazole Magnesium Capsule, Delayed Release19185.3185.5
Esomeprazole Magnesium Delayed Release Capsules19185.3185.5
Esomeprazole Magnesium Dihydrate19184.5184.7
Telmisartan22178.0178.2
Linagliptin22174.2174.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.